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A Commentary on
Bioceramics and Scaffolds: A Winning Combination for Tissue Engineering
By Baino, F., Novajra, G., and Vitale-Brovarone, C. (2015). Front. Bioeng. Biotechnol. 3:202. 
doi: 10.3389/fbioe.2015.00202
We read with interest the review published by Baino et al. (2015) about bioceramics and scaffolds. We 
would like to add some information as we produce a porous alumina ceramic (CERAMIL®) which 
present almost all the criteria that characterize an ideal scaffold as presented in table 1 of the article. 
Converse to the assertion that porous alumina is only used in the fabrication of orbital implants, 
our ceramic is widely implanted as vertebra cages and gap filling during opening wedge high tibial 
osteotomy. It has been recently implanted for the replacement of a tumor sternum.
The ceramic used is an alumina porous one processed thanks to a patented process [Patent 
FR2823674 (2006)].
Our technic seems to be in accordance to every point listed by the authors:
Geometry: several shapes are designed such as cubes, roof tiles, cylinders, trapezoidal parallelepi-
ped, spheres, and complex one such as the sternum with holes for stitching. 3D complex shapes can 
be designed and small bones can easily be done (Figure 1).
Bioactivity: the porous characteristic (see below) allows a rapid attachment of osteoblasts to the 
ceramic, and its integration has been studied by histopathology showing in-growth bone cell in 
pores. This characteristic leads to long-term bonding between ceramic and surrounding bone.
Biocompatibility: more than 5,000 implantations have been performed with vertebra cages, and the 
long-term follow-up does not show any case of local or systemic toxic effect. Studies are ongoing to 
analyze activity of bone cell in contact with the ceramic. Furthermore, alumina ceramic are classified 
as inert with no interaction with the surrounding tissues (Patel and Gohil, 2012; Baino et al., 2015).
Chemical and biological stability: as said by the authors, alumina has a very good bioinertness and 
good long-term mechanical properties without degradation (Baino et al., 2015).
Porous structure: with the technic used to fabricate our ceramic, the size of the interconnected 
pores is ranging from 100 to 900 μm with a vast majority of pore of about 600 to 900 μm. Moreover, 
all the pores are interconnected, without dead-end. This structure allows colonization with bone 
cells and thus the stability of the ceramic in the bone (Bignon et al., 2003; Hing, 2005; Lew et al., 
2012). Moreover, pore’s size ranging from 600 to 1,250 μm seems to be the ones that allow the best 
colonization by bone cells (Bignon et al., 2003).
Mechanical competence: the ceramic possess a mechanical compressive resistance superior to 
20  MPa. This resistance is superior to the bone one (1–7  MPa as defined by the French Society 
for Research in Orthopaedic Surgery & Traumatology). The resistance is proofed in  vivo as it is 
used without any problem as a gap filling during opening wedge high tibial osteotomy. Moreover, 
clinical trials conducted for over 15 years, using implants of the range CERAMIL®, confirmed the 
consistency of the selection made. For example, Finiels (2004) observed a good mechanical stability 
and a bone fusion using porous alumina ceramic.
Biological properties: as previously said, alumina ceramic is inert, so there is no release of ions or 
other substance.
FiGure 1 | (a) Corporectomy cervical bloc, (B) intersomatic cylinder, (C) trepan hole filling pellets, and (D) sternal implant.
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Fabrication: CERAMIL® process allows us to tailor pieces 
that can fit bone defect such as those seen in tumor or complex 
infection bone surgery. All implants are proposed in many sizes in 
order to allow the surgeon to choose the right one during surgery, 
depending on the amount of tissues removed or based on the 
modification needed.
Commercialization: the ceramic we proposed is already 
commercialized in several countries (France, Italy, and Czech 
Republic) and is approved by ANSM (French National agency of 
medicine products safety). CERAMIL products possess the CE 
marking.
We would like to add another characteristic that is particularly 
of interest for an implant which is its resistance to infection. We 
showed that the amount of adherent Staphylococcus aureus strains 
is lower on alumina structure than on other classical material used 
for joint prosthesis and that the biofilm formation was lower on 
this material in comparison to polyethylene, titanium, or stainless 
steel (unpublished data). It seems to be confirmed in vivo as only 1 
tibial osteotomy wedge has been infected among more than 5,000 
implanted devices.
In conclusion, our porous alumina ceramic seems to possess 
all the characteristics listed by Baino et al. required to be a good 
scaffold. We wanted to let the readers know that such a ceramic 
is not used only in the fabrication of orbital implants but that 
it is already implanted for other clinical indication. Researches 
are still ongoing to improve the performances of this ceramic 
and to produce new shapes in order to help surgeons to restore 
bone structures in patients suffering of bone infection or bone 
tumors.
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